Close

Rigel Pharmaceuticals, Inc. (RIGL) Posts Q2 Loss of 26c/Share

August 6, 2013 7:39 AM EDT
Rigel Pharmaceuticals, Inc. (NASDAQ: RIGL) reported Q2 EPS of ($0.26), $0.04 better than the analyst estimate of ($0.30). Revenue for the quarter came in at $1.4 million versus the consensus estimate of $530 thousand.

For earnings history and earnings-related data on Rigel Pharmaceuticals, Inc. (RIGL) click here.


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings

Related Entities

Earnings